Michael A. Hajost - Feb 7, 2023 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role
Chief Financial Officer
Signature
/s/ Michael Hajost
Stock symbol
DNMR
Transactions as of
Feb 7, 2023
Transactions value $
-$61,345
Form type
4
Date filed
2/9/2023, 04:00 PM
Previous filing
Apr 4, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNMR Class A Common Stock Options Exercise +38.7K 38.7K Feb 7, 2023 Direct F1
transaction DNMR Class A Common Stock Tax liability -$34.6K -13.7K -35.4% $2.53 25K Feb 7, 2023 Direct
transaction DNMR Class A Common Stock Options Exercise +34.4K +137.6% 59.3K Feb 7, 2023 Direct F1
transaction DNMR Class A Common Stock Tax liability -$26.7K -10.6K -17.8% $2.53 48.8K Feb 7, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNMR RSU Award Options Exercise $0 -38.7K -100% $0.00* 0 Feb 7, 2023 Class A Common Stock 38.7K Direct F1, F2
transaction DNMR RSU Award Options Exercise $0 -34.4K -33.33% $0.00 68.7K Feb 7, 2023 Class A Common Stock 34.4K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On March 31, 2022, the reporting person was granted 38,659 restricted stock units, which are vesting on February 7, 2023.
F3 On March 31, 2022, the reporting person was granted 103,092 restricted stock units. 34,364 restricted stock units are vesting on February 7, 2023, February 7, 2024, and February 7, 2025.